Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report

Journal of Medical Case Reports
Mohammad Ali SahraianAlireza Minagar

Abstract

Several cases of sarcoidosis following treatment with interferon-α have been reported in the literature, but those following interferon-β are very rare. We report the case of a patient with multiple sclerosis who developed pulmonary and cutaneous sarcoidosis following treatment with Betaseron® (interferon-β-1b). A 33-year-old Caucasian woman with a history of multiple sclerosis, treated with interferon-β-1b for 2.5 years developed erythema nodosum in her lower limbs, a breast abscess, and unilateral adenopathy of her left lung. A skin biopsy confirmed sarcoidosis. After the discontinuation of interferon-β-1b and treatment with indomethacin and prednisolone, she recovered. Sarcoidosis is considered one of the most common multiple sclerosis imitators with involvement of the central nervous system. However, although rare, sarcoidosis can develop following treatment with interferon-β-1b and should be considered in patients with multiple sclerosis treated with beta-interferons who develop pulmonary or extra-pulmonary manifestations of sarcoidosis. Interferon-β-1b discontinuation is the first and most important step in the treatment of such cases followed by treatment with corticosteroids.

References

Mar 1, 1978·Archives of Internal Medicine·A Sybert, T P Butler
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Zumla, D G James
Oct 8, 1998·The European Respiratory Journal·J Müller-Quernheim
Dec 8, 1998·Journal of the American Academy of Dermatology·C L MehtaD J Cripps
Feb 3, 2006·International Journal of Clinical Practice·S Alazemi, M A Campos
Sep 26, 2007·Annals of the New York Academy of Sciences·Uriel KatzPnina Langevitz
May 11, 2012·Seminars in Arthritis and Rheumatism·Soumya D ChakravartyMary K Crow
Oct 10, 2012·Journal of Medical Case Reports·Nayia Petousi, Enson C Thomas
Oct 30, 2012·Immunology and Allergy Clinics of North America·Daniel A Culver
Nov 2, 2012·Current Opinion in Rheumatology·Roberto Perez-AlvarezUNKNOWN BIOGEAS study group
Apr 12, 2013·BMJ Case Reports·Monica GuptaMala Bhalla

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.